Immunomodulatory action of the DNA methyltransferase inhibitor SGI-110 in epithelial ovarian cancer cells and xenografts-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immunomodulatory action of the DNA methyltransferase inhibitor SGI-110 in epithelial ovarian cancer cells and xenografts

Published:2015-03-04 Issue:3 Volume:10 Page:237-246
ISSN:1559-2294
Container-title:Epigenetics
language:en
Short-container-title:Epigenetics

Author:

Srivastava Pragya,Paluch Benjamin E,Matsuzaki Junko,James Smitha R,Collamat-Lai Golda,Taverna Pietro,Karpf Adam R,Griffiths Elizabeth A

Publisher

Informa UK Limited

Subject

Cancer Research,Molecular Biology

Link

http://www.tandfonline.com/doi/pdf/10.1080/15592294.2015.1017198

Reference44 articles.

1. Intertumor and Intratumor NY-ESO-1 Expression Heterogeneity Is Associated with Promoter-Specific and Global DNA Methylation Status in Ovarian Cancer

2. Methylation and expression analysis of 15 genes and three normally-methylated genes in 13 Ovarian cancer cell lines

3. Survey of naturally occurring CD4+ T cell responses against NY-ESO-1 in cancer patients: Correlation with antibody responses

4. Serologic analysis of ovarian tumor antigens reveals a bias toward antigens encoded on 17q

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. iMN041 is an immunotherapeutic and an effective treatment in mouse xenograft models of pancreatic cancer, renal cancer and triple negative breast cancer;Translational Medicine Communications;2024-01-19

2. Melanoma Antigen Family A (MAGE A) as Promising Biomarkers and Therapeutic Targets in Bladder Cancer;Cancers;2024-01-05

3. Epigenetic regulation of androgen dependent and independent prostate cancer;Advances in Cancer Research;2024

4. Strategies to synergize PD-1/PD-L1 targeted cancer immunotherapies to enhance antitumor responses in ovarian cancer;Biochemical Pharmacology;2023-09

5. Challenges and solutions for therapeuticTCR‐based agents;Immunological Reviews;2023-07-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3